Institute of Molecular Genetics of the Czech Academy of Sciences
| Grant name | Provider | Duration | Investigator | Web |
|---|---|---|---|---|
| Grant name Decoding unique metabolic dispositions of malignant clones responsible for adverse prognosis in acute lymphoblastic leukemia: cancer metabolism as a new therapeutic target in leukemias | Provider Ministry of Health | Duration 2022-2025 | Investigator M. Alberich Jordà | Web Go to website |
| Grant name Exploring emergency granulopoiesis under sterile chronic inflammation | Provider Czech Science Foundation | Duration 2024-2026 | Investigator M. Alberich Jordà | Web Go to website |
| Grant name Dissecting the role of bone marrow microenvironment behind chemoresistance development in acute lymphoblastic leukemia | Provider Ministry of Health | Duration 2024-2027 | Investigator M. Alberich Jorda | Web Go to website |
| Grant name Deciphering transcriptional regulation and metabolic adaptations during emergency granulopoiesis in hematopoietic stem cells | Provider Czech Science Foundation | Duration 2025-2027 | Investigator M. Alberich Jorda | Web |
| Grant name | Provider | Duration | Investigator | Web |
|---|---|---|---|---|
| Grant name C/EBPgamma in normal hematopoiesis and acute myeloid leukemia: identification of molecular mechanisms involved in cell transformation | Provider Ministry of Education, Youth and Sports | Duration 2013-2015 | Investigator M. Alberich-Jorda | Web Go to website |
| Grant name Function of the transmembrane protein Evi2b in hematopoiesis | Provider Czech Science Foundation | Duration 2015-2017 | Investigator M. Alberich Jorda | Web Go to website |
| Grant name Mechanisms regulating normal and leukemic hematopoietic stem cells: Deciphering the role of the beta-catenin/Tcf signaling pathway | Provider Czech Science Foundation | Duration 2017-2019 | Investigator M. Alberich Jorda | Web Go to website |
| Grant name The transcription factor C/EBPg as a novel regulator in mast cell development and function | Provider Czech Science Foundation | Duration 2018-2020 | Investigator M. Alberich Jorda | Web Go to website |
| Grant name Role of leukemia cell metabolism in disease manifestation, progression and therapy response | Provider Ministry of Health | Duration 2018-2021 | Investigator M. Alberich Jorda | Web Go to website |
| Grant name Effects of chronic inflammation on hematopoietic stem cells and leukemia development | Provider Czech Science Foundation | Duration 2020-2022 | Investigator M. Alberich Jorda | Web Go to website |
| Grant name Molecular basis of human enhanceropathies | Provider EU Framework Programme for Research and Innovation | Duration 2020-2024 | Investigator M. Alberich Jorda | Web Go to website |
| Grant name Evaluation of ALDH1A inhibitors as a potential drugs in the treatment of acute myeloid leukemia by using patient-derived xenografts | Provider Czech Academy of Sciences | Duration 2021-2023 | Investigator MK. Adamcová | Web |
| Grant name Emergency granulopoiesis at the level of hematopoietic stem and progenitor cells: The role of population dynamics and Wnt/-catenin signaling | Provider Czech Science Foundation | Duration 2022-2024 | Investigator M. Alberich Jordà | Web Go to website |
